Epidemiology of IgA nephropathy: a global perspective

FP Schena, I Nistor - Seminars in nephrology, 2018 - Elsevier
IgA nephropathy (IgAN), or Berger's disease, is the most common primary glomerular
disease worldwide, but varies largely in its geographic distribution. A systematic review of …

[HTML][HTML] Unraveling the racial disparities associated with kidney disease1

KC Norris, LY Agodoa - Kidney international, 2005 - Elsevier
Unraveling the racial disparities associated with kidney disease. In the United States,
chronic kidney disease (CKD), and in particular end-stage renal disease (ESRD), represent …

[HTML][HTML] Genetic and environmental risk factors for chronic kidney disease

GT Obrador, UT Schultheiss, M Kretzler… - Kidney international …, 2017 - Elsevier
In order to change the current state of chronic kidney disease knowledge and therapeutics, a
fundamental improvement in the understanding of genetic and environmental causes of …

Chronic kidney disease in the general population

SL White, A Cass, RC Atkins, SJ Chadban - Advances in chronic kidney …, 2005 - Elsevier
End-stage kidney disease (ESKD), defined as the need for dialysis, receipt of a transplant, or
death from chronic kidney failure, generally affects fewer than 1% of the population …

Resistant starch as a dietary intervention to limit the progression of diabetic kidney disease

AM Drake, MT Coughlan, CT Christophersen… - Nutrients, 2022 - mdpi.com
Diabetes is the leading cause of kidney disease, and as the number of individuals with
diabetes increases there is a concomitant increase in the prevalence of diabetic kidney …

New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy

MJ Soler, M Riera, D Batlle - Journal of Diabetes Research, 2012 - Wiley Online Library
Diabetic nephropathy (DN) is the leading cause of end‐stage renal disease. The use of
experimental models of DN has provided valuable information regarding many aspects of …

Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in …

R Reilly, K Evans, J Gomersall, G Gorham… - BMC health services …, 2016 - Springer
Abstract Background Indigenous peoples in Australia, New Zealand and Canada carry a
greater burden of chronic kidney disease (CKD) than the general populations in each …

Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy

BS Grace, P Clayton, SP McDonald - Nephrology, 2012 - Wiley Online Library
Aim: The incidence of end‐stage kidney disease (ESKD) has been increasing worldwide,
with increasing numbers of older people, people with diabetic nephropathy and indigenous …

The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease

A White, W Wong, P Sureshkumur… - Journal of paediatrics …, 2010 - Wiley Online Library
Aims: To review and present the most important issues related to kidney disease in
Aboriginal, Torres Strait Islander, Maori and Pacific Islander children from Australia and New …

Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis

T Huria, S Palmer, L Beckert, J Williman… - International Journal for …, 2018 - Springer
Abstract Background In Aotearoa/New Zealand, Māori, as the indigenous people,
experience chronic kidney disease at three times the rate of non-Māori, non-Pacific New …